Preclinical and clinical studies of a tumor targeting IL-12 immunocytokine
Article in Frontiers in Oncology (January 2024)
The most recent citing publications are shown below. View all 21 publications that cite this research output on Dimensions.
Nanobodies in cytokine‑mediated immunotherapy and immunoimaging (Review)
Article in International Journal of Molecular Medicine (December 2023)
First-in-human phase Ib trial of M9241 (NHS-IL12) plus avelumab in patients with advanced solid tumors, including dose expansion in patients with advanced urothelial carcinoma
Article in Journal for ImmunoTherapy of Cancer (May 2023)